Current Perspective in Mixed Pain

  • María del Rocío Guillén-Núñez Anesthesiologist; Pain Management, Interventional Pain Management & Palliative Care, attending physician at Pain Clinic, National Cancer Institute, Mexico; General Director of Clínica Alive "Vive sin Dolor"; Mexico https://orcid.org/0000-0001-8293-8286
  • Angel Manuel Juárez-Lemus Anesthesiologist; Pain Management, Interventional Pain Management & Palliative Care, at Pain Clinic, National Cancer Institute, Mexico; Medical Director of Clínica Alive "Vive sin Dolor"; Mexico https://orcid.org/0000-0002-6075-9815
  • Berenice Carolina Hernández-Porras Anesthesiologist; Oncologic Anesthesiology, Pain Management & Interventional Pain Management, attending physician at Pain Clinic, National Cancer Institute, Mexico; Pain management specialist at ABC Medical Center
  • Daniela Hernández-Rodríguez Anesthesiologist & Pain Management; Fellow in Interventional Pain Management at Pain Clinic, National Cancer Institute, Mexico https://orcid.org/0009-0007-0851-7070

Abstract

Pain is one of the 10 leading causes of medical consultation worldwide and is the alarm symptom of the organism in situations that threaten its integrity, however, when it becomes chronic, it loses its protective capacity and becomes, in many cases, the disease itself.


According to the International Association for the Study of Pain (IASP) pain is classified as nociceptive, neuropathic and nociplastic. Mixed pain has been described years ago due to the coexistence of different types of pain.


We can conclude that we do not have a screening tool and/or treatment algorithm for mixed pain, so it is preferable that pain management begins with a rigorous assessment, using the latest available tools, followed by individualized evidence-based treatment with multimodal therapy when appropriate.


Keywords: nociceptive pain, neuropathic pain, mixed pain.

Keywords: nociceptive pain, neuropathic pain, mixed pain

Downloads

Download data is not yet available.

Author Biographies

María del Rocío Guillén-Núñez, Anesthesiologist; Pain Management, Interventional Pain Management & Palliative Care, attending physician at Pain Clinic, National Cancer Institute, Mexico; General Director of Clínica Alive "Vive sin Dolor"; Mexico

Anesthesiologist; Pain Management, Interventional Pain Management & Palliative Care, attending physician at Pain Clinic, National Cancer Institute, Mexico; General Director of Clínica Alive "Vive sin Dolor"; Mexico

Angel Manuel Juárez-Lemus, Anesthesiologist; Pain Management, Interventional Pain Management & Palliative Care, at Pain Clinic, National Cancer Institute, Mexico; Medical Director of Clínica Alive "Vive sin Dolor"; Mexico

Anesthesiologist; Pain Management, Interventional Pain Management & Palliative Care, at Pain Clinic, National Cancer Institute, Mexico; Medical Director of Clínica Alive "Vive sin Dolor"; Mexico

Berenice Carolina Hernández-Porras, Anesthesiologist; Oncologic Anesthesiology, Pain Management & Interventional Pain Management, attending physician at Pain Clinic, National Cancer Institute, Mexico; Pain management specialist at ABC Medical Center

Anesthesiologist; Oncologic Anesthesiology, Pain Management & Interventional Pain Management, attending physician at Pain Clinic, National Cancer Institute, Mexico; Pain management specialist at ABC Medical Center

Daniela Hernández-Rodríguez, Anesthesiologist & Pain Management; Fellow in Interventional Pain Management at Pain Clinic, National Cancer Institute, Mexico

Anesthesiologist & Pain Management; Fellow in Interventional Pain Management at Pain Clinic, National Cancer Institute, Mexico

References

1. Guillén-Núñez MR, Juárez-Lemus AM. Algología para no algólogos, Siegfried Rhein, 2020; 15-24.
2. Freynhagen R, Parada HA, Calderon-Ospina CA, Chen J, Rakhmawati Emril D, Fernández-Villacorta FJ, et al. Current understanding of the mixed pain concept: a brief narrative review. Curr Med Res Opin. 2019;35(6):1011-1018. https://doi.org/10.1080/03007995.2018.1552042 PMid:30479161
3. Kosek E, Cohen M, Baron R, Gebhart GF, Mico JA, Rice ASC, Rief W, Sluka AK. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382-1386. https://doi.org/10.1097/j.pain.0000000000000507 PMid:26835783
4. Benaña J. Dolor neuropático: actualización en definiciones y su tratamiento farmacológico. Rev Med Hondur; 2020; 88(1): 48-51. https://doi.org/10.5377/rmh.v88i1.11591
5. Trouvin AP, Perrot S. New concepts of pain. Best Pract Res Clin Rheumatol. 2019;33(3):101415. https://doi.org/10.1016/j.berh.2019.04.007 PMid:31703792
6. Argoff C. Distinguishing Neuropathic, Non-Neurophatic, and Mixed Pain. Pract Pain Manag, 2017;17(1).
7. Baron R, Binder A, Attal N, Casale R, Dickenson AH, Treede RD. Neuropathic low back pain in clinical practice. Eur J Pain. 2016;20(6):861-873. https://doi.org/10.1002/ejp.838 PMid:26935254 PMCid:PMC5069616
8. Ito S, Kobayashi D, Murasawa A, Narita I, Nakazono K. An Analysis of the Neuropathic Pain Components in Rheumatoid Arthritis Patients. Intern Med. 2018;57(4):479-485. https://doi.org/10.2169/internalmedicine.9235-17 PMid:29225253 PMCid:PMC5849541
9. Ibor PJ, Sánchez-Magro I, Villoria J, Leal A, Esquivias A. Mixed Pain Can Be Discerned in the Primary Care and Orthopedics Settings in Spain: A Large Cross-Sectional Study. Clin J Pain. 2017;33(12):1100-1108. https://doi.org/10.1097/AJP.0000000000000491 PMid:28244943
10. Perrot S. Osteoarthritis pain. Best Pract Res Clin Rheumatol 2015; 29:90-97. https://doi.org/10.1016/j.berh.2015.04.017 PMid:26267003
11. Zolio L, Lim KY, McKenzie JE, Yan MK, Estee M, Hussain SM, Cicuttini F, Wluka A. Systematic review and meta-analysis of the prevalence of neuropathic-like pain and/or pain sensitization in people with knee and hip osteoarthritis. Osteoarthritis Cartilage. 2021;29(8):1096-1116. https://doi.org/10.1016/j.joca.2021.03.021 PMid:33971205
12. Grond S, Radbruch L, Meuser T, Sabatowski R, Loick G, Lehmann KA. Assessment and treatment of neuropathic cancer pain following who guidelines. Pain. 1999 Jan 1;79(1):15-20. https://doi.org/10.1016/S0304-3959(98)00138-9 PMid:9928771
13. Fainsinger RL, Nekolaichuk C, Lawlor P et al. An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer 2010;46:2896-904. https://doi.org/10.1016/j.ejca.2010.04.017 PMid:20483589
14. Bennett MI, Rayment C, Hjermstad M, Aass N et al. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain. 2012 Feb;153(2):359-365. https://doi.org/10.1016/j.pain.2011.10.028 PMid:22115921
15. Reis-Pina P, Acharya A, Lawlor, P. Cancer pain with a neuropathic component: a cross-sectional study of its clinical characteristics, associated psychological distress, treatments, and predictors at referral to a cancer pain clinic. Journal of pain and symptom management, 2018, 55(2), 297-306. https://doi.org/10.1016/j.jpainsymman.2017.08.028 PMid:28870800
16. Higashibata T, Tagami K, Miura T, Okizaki A, Watanabe Y et al. Usefulness of painDETECT and S-LANSS in identifying the neuropathic component of mixed pain among patients with tumor-related cancer pain. Supportive Care in Cancer, 2020: 28(1), 279-285. https://doi.org/10.1007/s00520-019-04819-9 PMid:31041583
17. Fallon MT. Neuropathic pain in cancer. Br J Anaesth. 2013;111(1):105-111. https://doi.org/10.1093/bja/aet208 PMid:23794652
18. Freynhagen R, Rey R, Argoff Ch. When to consider "mixed pain"? The right questions can make a difference! Current Medical Research and Opinion, 2020, 36:12, 2037-2046. https://doi.org/10.1080/03007995.2020.1832058 PMid:33012210
Crossmark
Statistics
42 Views | 3 Downloads
How to Cite
1.
Guillén-Núñez M del R, Juárez-Lemus AM, Hernández-Porras BC, Hernández-Rodríguez D. Current Perspective in Mixed Pain. JDDT [Internet]. 15Mar.2024 [cited 18Apr.2024];14(3):170-3. Available from: https://jddtonline.info/index.php/jddt/article/view/6451